Phospholipid Component Defines Pharmacokinetic and Pharmacodynamic Properties of Synthetic High-Density Lipoproteins.
J Pharmacol Exp Ther
; 372(2): 193-204, 2020 02.
Article
in En
| MEDLINE
| ID: mdl-31776208
Full text:
1
Collection:
01-internacional
Health context:
1_ASSA2030
Database:
MEDLINE
Main subject:
Peptides
/
Phospholipids
/
Apolipoprotein A-I
/
Nanoparticles
/
Lipoproteins, HDL
Type of study:
Prognostic_studies
Limits:
Animals
/
Humans
/
Male
Language:
En
Journal:
J Pharmacol Exp Ther
Year:
2020
Document type:
Article